Cassava Sciences, Alzheimer
Hoau-Yan Wang, a professor at City College, published studies supporting simufilam, now in advanced clinical trials.
The Chicago Tribune reports that a new system to help fair distribution of donor lungs was built on a flawed algorithm which harmed some sick and dying patients. Meanwhile a researcher was indicted on ...
Genevieve Lane, who took Leqembi, died of a mysterious side effect called ARIA. Her death, and those of two other trial ...
Breakthrough is going to help treatment and drug trials, scientists say Charles Marshall thinks he can now predict who will get dementia up to nine years before their symptoms appear, with a ...
Scientists studying a family plagued by early Alzheimer’s found some carry a genetic oddity that delays their symptoms ...
Journal Editorial Report: The week's best and worst from Bill McGurn, Allysia Finley, Mene Ukueberuwa and Dan Henninger. Image: Cristobal Herrera-Ulashkevich ...
Boston researchers say they’ve created a promising AI model that predicts the likelihood of someone developing Alzheimer’s ...
In a promising study for Alzheimer's disease, scientists in Japan say they have reversed the signs of this debilitating ...
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers Monday, setting the stage for the treatment's expected approval for people with mild dementia caused ...
Hoau-Yan Wang, a 67-year-old tenured medical professor, was indicted this week for an alleged scheme involving fraudulent ...